BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 8437272)

  • 1. Squamous cell carcinoma of the bladder associated with cyclophosphamide therapy for Wegener's granulomatosis: a report of 2 cases.
    Stein JP; Skinner EC; Boyd SD; Skinner DG
    J Urol; 1993 Mar; 149(3):588-9. PubMed ID: 8437272
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Spindle cell cancer of bladder during cyclophosphamide therapy for Wegener's granulomatosis.
    Chasko SB; Keuhnelian JG; Gutowski WT; Gray GF
    Am J Surg Pathol; 1980 Apr; 4(2):191-6. PubMed ID: 7377464
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Squamous cell carcinoma of the nasal septum with Wegener's granulomatosis treated with cyclophosphamide and corticosteroids.
    Wakisaka N; Tanaka S; Nagayama I; Furukawa M
    Auris Nasus Larynx; 1998 Dec; 25(4):393-6. PubMed ID: 9853662
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Renal cell carcinoma associated with cyclophosphamide therapy for Wegener's granulomatosis.
    Odeh M
    Scand J Rheumatol; 1996; 25(6):391-3. PubMed ID: 8996475
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Urinary bladder cancer in Wegener's granulomatosis: risks and relation to cyclophosphamide.
    Knight A; Askling J; Granath F; Sparen P; Ekbom A
    Ann Rheum Dis; 2004 Oct; 63(10):1307-11. PubMed ID: 15130900
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cyclophosphamide-induced bladder toxicity in Wegener's granulomatosis.
    Stillwell TJ; Benson RC; DeRemee RA; McDonald TJ; Weiland LH
    Arthritis Rheum; 1988 Apr; 31(4):465-70. PubMed ID: 3358809
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Carcinoma of the urinary bladder in a patient receiving cyclophosphamide for Wegener's granuloma: a case report].
    Shiba T; Noguchi S; Yao M; Takahashi T; Shuin T; Miura T; Kinoshita Y; Kubota Y; Hosaka M
    Hinyokika Kiyo; 1991 Apr; 37(4):393-6. PubMed ID: 1891999
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cyclophosphamide-induced cystitis and bladder cancer in patients with Wegener granulomatosis.
    Talar-Williams C; Hijazi YM; Walther MM; Linehan WM; Hallahan CW; Lubensky I; Kerr GS; Hoffman GS; Fauci AS; Sneller MC
    Ann Intern Med; 1996 Mar; 124(5):477-84. PubMed ID: 8602705
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diffuse histiocytic lymphoma in a patient treated with cyclophosphamide for Wegener's granulomatosis.
    Ambrus JL; Fauci AS
    Am J Med; 1984 Apr; 76(4):745-7. PubMed ID: 6369981
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Cyclophosphamide-induced bladder cancer in a patient with Wegener granuromatosis].
    Shimizu A; Ueda T; Furuya Y; Ichikawa T; Akakura K; Ito H; Matsuzaki O; Isaka S
    Nihon Hinyokika Gakkai Zasshi; 1999 Jan; 90(1):53-6. PubMed ID: 10067308
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Simultaneous occurrence of transitional, squamous and adenocarcinoma of the bladder after 15 years of cyclophosphamide ingestion.
    Chodak GW; Straus FW; Schoenberg HW
    J Urol; 1981 Mar; 125(3):424-6. PubMed ID: 7206101
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Wegener's granulomatosis. Long-term followup of patients treated with cyclophosphamide.
    Reza MJ; Dornfeld L; Goldberg LS; Bluestone R; Pearson CM
    Arthritis Rheum; 1975; 18(5):501-6. PubMed ID: 1191350
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cancer incidence in a population-based cohort of patients with Wegener's granulomatosis.
    Knight A; Askling J; Ekbom A
    Int J Cancer; 2002 Jul; 100(1):82-5. PubMed ID: 12115591
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Carcinosarcoma of the urinary bladder following cyclophosphamide therapy: evidence for monoclonal origin and chromosome 9p allelic loss.
    Mukhopadhyay S; Shrimpton AE; Jones LA; Nsouli IS; Abraham NZ
    Arch Pathol Lab Med; 2004 Jan; 128(1):e8-11. PubMed ID: 14692829
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prolonged risk of specific malignancies following cyclophosphamide therapy among patients with granulomatosis with polyangiitis.
    Faurschou M; Mellemkjaer L; Voss A; Keller KK; Hansen IT; Baslund B
    Rheumatology (Oxford); 2015 Aug; 54(8):1345-50. PubMed ID: 25234661
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Does hepatocellular carcinoma develop after treatment of Wegener's granulomatosis with cyclophosphamide?
    Ueno T; Sata M
    Intern Med; 2003 May; 42(5):379-80. PubMed ID: 12793704
    [No Abstract]   [Full Text] [Related]  

  • 17. [A case of pulmonary metastases from bladder cancer, suspected of recurrent Wegener's granulomatosis].
    Sekiya M; Ichikawa M; Tsutsui A; Yoshimi K; Suzuki T; Seyama K; Uekusa T; Takahashi K
    Nihon Kokyuki Gakkai Zasshi; 2009 Oct; 47(10):943-6. PubMed ID: 19882920
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cyclophosphamide-induced hepatotoxicity in a patient with Wegener's granulomatosis.
    Snyder LS; Heigh RI; Anderson ML
    Mayo Clin Proc; 1993 Dec; 68(12):1203-4. PubMed ID: 8246624
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cyclophosphamide-induced bladder cancer.
    Gossmann J
    Ann Intern Med; 1997 Jan; 126(1):86. PubMed ID: 8992929
    [No Abstract]   [Full Text] [Related]  

  • 20. Cyclophosphamide-induced hepatitis in Wegener's granulomatosis.
    Du LT; Rigaud D; Papo T; Godeau P
    Mayo Clin Proc; 1994 Sep; 69(9):912-3. PubMed ID: 8065199
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.